Alcohols And The Pharmacotherapy Of Alcoholism

Embed Size (px)

Citation preview

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    1/36

    ALCOHOLS AND PHARMACOTHERAPY OFALCOHOLISM

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    2/36

    INTRODUCTION

    x When unqualified, 'alcohol' refers to ethyl

    alcohol or ethanol

    x Alcohol beverages have been used since

    recorded history

    x Alcohol is known for intoxication. Rather than as adrug

    x Alcohol is the most commonly abused drug in theworld

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    3/36

    x Alcohol abuse: inability to limit alcoholconsumption - becomes a health risk

    x Alcoholism: continued consumption of alcohol

    in spite of adverse medical or socialconsequences related directly to alcohol

    consumption

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    4/36

    Rapidly absorbed from GIT

    x Peak levels in 30 min on empty stomach

    x Food delays absorptionx Rapid distribution in total body water, tissue

    and blood levels almost similar

    x Women have higher peak concentrationsx Concentration rises quickly in CNS

    PHARMACOKINETICS

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    5/36

    x Over 90% is oxidized in the liver; remainder is

    excreted through the lungs and in the urine

    x Metabolism follows zero-order kinetics;

    independent of time and conc. of the drug

    x A typical adult can metabolize 7-10 g/hr

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    6/36

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    7/36

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    8/36

    x During chronic alcohol consumption, MEOS

    activity is induced

    x Significant in ethanol metabolism and also in

    the clearance of other drugsx Increased generation of the toxic byproducts of

    cytochrome P450 reactions

    x Deficient activity of ALDH -disulifiram like

    effects; protective against alcoholism; risk ofsevere liver disease

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    9/36

    PHARMACOLOGICAL ACTIONS

    Local actions:x Has mild rubefacient counterirritant andastringent action

    x Used as an antiseptic

    CNS:

    x Alcohol is a neuronal depressant

    x Higher areas are most sensitive (primarilyinhibitory) - apparent excitation and euphoria

    at lower concentrations

    x Gradual CNS depression with increasingconcentrations

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    10/36

    x Alcohol can induce sleep

    x Increases pain threshold and also alters

    reaction to itx Effects are more marked when the blood

    concentration is rising

    x Cortex & RAS are most sensitive

    x Chronic alcoholism may lead to peripheral

    neuropathy, Wernicke-Korsakoff syndrome

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    11/36

    CVS: dose & duration dependent effects

    x Smaller doses cause cutaneous and gastric

    vasodilatation, BP not affectedx Voderate doses: tachycardia and mild rise in

    BP - due to sympathetic stimulation

    x Large doses cause fall in BP due to direct

    myocardial as well as VMC depression anddirect smooth muscle relaxation

    x Chronic alcoholism contributes to hypertension,cardiomyopathy and arrhythmias

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    12/36

    Blood:

    x Consumption in moderation increase HDL

    x Megaloblastic anemia due to interference of

    folate metabolism (diminished hepatic storage)

    Respiration:

    x Transiently stimulate respiration reflexly

    x Directly depress respiratory centre

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    13/36

    GIT:

    x Directly and reflexly stimulate gastric secretion

    x Higher conc. (>20%) inhibit gastric secretioncause vomiting, mucosal congestion & gastritis

    x Lower esophageal sphincter (LES) tone is

    reduced - Ted gastroesophageal reflux

    x Risk of chronic pancreatitis & stones

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    14/36

    Liver:

    x R e d u ce d h e p a t ic g l u co n e o g e ne s i s c a n l e a d

    to hypoglycemia ( in acute intoxicat ion)

    Chronic a lcohol a b u s e le a d s t o r e v e r sib le

    f a t ty l iv e r p r o g r e s s ing t o i r r e ve r s ib le

    h e p a ti t is , c i r r h o s is a n d l iv e r f a i lur e

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    15/36

    Body temperature:

    x Produce a sense of warmth due to cutaneous

    and gastric vasodilatationx Temperature regulating centre depressed at

    higher dose

    Skeletal muscle:

    x Fatigue is allayed by small dosesx Weakness and myopathy in chronic alcoholism

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    16/36

    Endocrine effects:

    x Moderate amounts - cause hyperglycaemiax Acute intoxication is associated with

    hypoglycaemiax Chronic alcoholism can produce impotence,testicular atrophy, gynaecomastia etc. (altered

    Steroid balance)x Reputed as an aphrodisiac

    Kidney:

    x Can induce diuresis (ADH inhibition)

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    17/36

    Fetal Alcohol Syndrome:

    x Chronic maternal alcohol abuse during

    pregnancy is associated with teratogenic

    effects (leading cause of mental retardation

    and congenital malformation)

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    18/36

    Immune System:

    x Immune function in some tissues is inhibited

    (e.g, the lung), whereas pathologic, hyperactiveimmune function in other tissues is triggered

    (e.g, liver, pancreas)

    Neoplasia: chronic use increase risk of GI

    cancers and also risk of breast cancer

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    19/36

    MECHANISM OF ACTION

    x Ethanol affects a large number of membraneproteins

    Neurotransmitter receptors

    Enzymes

    Transporter

    and ion channels

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    20/36

    x Enhancement of the action of GABA at GABAAreceptors

    x Inhibits the ability of glutamate to open NMDA

    receptors

    x Action of 5-HT on 5-HT3 inhibitory autoreceptoris augmented

    x Can indirectly reduce neurotransmitter release

    by inhibiting voltage sensitive neuronal Ca2+channels

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    21/36

    x Blockade of adenosine uptake contribute tosynaptic depression

    x Increased turnover of NA, in brain through anopioid receptor dependent mechanism -

    important in the pleasurable effects ofalcohol and in the genesis of alcohol

    dependence

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    22/36

    x Activity of membrane bound enzymes like

    Na+K+ATPase and adenylyl cyclase may be

    altered

    x The activity and translocation of channel /

    enzyme proteins in the membrane could also

    be affected

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    23/36

    DRUG INTERACTIONS

    x Increases the risk of hepatotoxicity with

    acetaminophen

    x Additive CNS depression when combined withother CNS depressants

    x Disulfiram-like reactions with chlorpropamide,

    cefoperazone, cefotetan, moxalactam,

    cefamandole, metronidazole, trimethoprim etc.

    x Acute alcohol use may inhibit metabolism of

    sedative-hypnotics, TCAs, phenothiazines

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    24/36

    ALCOHOL TOLERANCE & DEPENDENCE

    x Tolerance - due to changes in the nervous

    system (upregulation of pathways) & changes

    in metabolic clearance

    x Dependence - both psychological & physical

    x Physical - responsible for "withdrawal reaction"

    x Psychological one is characterized bycompulsive desire to experience rewarding

    effects and in current drinkers - desire to avoidnegative effects of withdrawal

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    25/36

    ACUTE ALCOHOL INTOXICATION

    Sign and symptoms:

    x Vomiting, hypotension, tachycardia, gastritis,

    hypoglycaemia, respiratory depression & coma

    Treatment:

    x Prevent respiratory depression & aspiration of

    vomitus

    x Add adequate respiratory & CV support

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    26/36

    x Treatment of hypoglycemia and ketosis by

    administration of glucose infusion

    x Thiamine: 100 mg in 500 ml of glucosesolution infused intravenously

    x In case of dehydration and vomiting - give

    electrolyte solutions

    x Administer potassium and phosphate

    depending on the situation

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    27/36

    ALCOHOL WITHDRAWALSYNDROME

    x Characterized by motor agitation, anxiety,insomnia; seizure & hallucinations (severe)

    Treatment:

    x Aim is to prevent seizure, delirium & arrhythmia

    x Restore electrolyte balance (K+, mg2+ and

    phosphate)x Administer thiamine in all cases

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    28/36

    In severe cases substitute alcohol with BZD

    followed by gradually tapering of BZD dose over

    several weeks

    x Long acting BZD in those with normal liver

    function (e.g. chlordiazepoxide/ diazepam)

    x Short acting BZD in impaired liver function

    (oxazepam/ lorazepam)

    x Can be administered orally/ parenterally

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    29/36

    TREATMENT OF ALCOHOLISM

    x Started after successful detoxif icat ion

    x Drugs are helpfu l in mainta in ing abstinence

    and reducing craving (adjunctive therapy)

    Naltrexone:

    x Long acting opioid receptor antagonist

    x Avoid giving with disulf iram - hepatotoxicityx Pat ient should be opioid free

    x Dose: 50 mg OD oral ly/ IM inj every 4 wks

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    30/36

    Acamprosate:

    x Weak NMDA-receptor antagonist and a GABAA-

    receptor activator

    x Administered as 1-2 enteric coated tablets

    (333 mg) three times a day

    x Should not be used in patients with severe

    renal dysfunctionx GI adverse effects are important

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    31/36

    DISULFIRAM

    Acts by inhibiting "Aldehyde dehydrogenase"

    x Flushing, throbbing headache, nausea,

    vomiting, sweating, hypotension, and confusion

    occur within a few minutes after alcohol

    x No effect in non-drinkers

    x For full effect 12 hrs are required

    x Action persist several days after last dose

    x May impair liver function tests

    x Adherence to therapy is poor

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    32/36

    METHANOL POISONING & TREATMENT

    x Methanol is a CNS depressant

    x Toxic effects are largelydue to formic acid

    X Blood levels >50mg/di associated with severe

    poisoning

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    33/36

    Manifestations of methanol poisoning:

    x Vomiting, headache, dyspnoea, bradycardia

    and hypotension

    x Acidosis is prominent

    x Visual disturbances (like being in a snowstorm)

    progressing to blindness

    x Death is due to respiratory failure

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    34/36

    x Maintain respiration and BP

    x Suppression of metabolism by ALD to toxicproducts by ethanol (i.v.) or fomepizole

    (15mg/kg iv followed by 10 mg/kg/12hr tillmethanol level falls b e low 2 0 mg/dL)

    x Na-bicarbonate infusion to counteract acidosis

    x Hemodialysis to enhance removal of methanol

    and formate in severe casex Administration of folio acid (Ca-leucovorin 50mg/6 hrly)

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    35/36

    THANK YOU

  • 8/6/2019 Alcohols And The Pharmacotherapy Of Alcoholism

    36/36